Cite
HARVARD Citation
Nichols, C. et al. (n.d.). 535. Comparison of Outcomes in Patients Positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection After Monoclonal Antibody Therapy (MAT) with Bamlamivimab or Casirivimab-Imdevimab. Open forum infectious diseases. p. S369. [Online].